BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23966458)

  • 1. Low complement levels in paediatric systemic lupus erythematosus and the risk of bacteraemia.
    Hagen JP; Muller PC; Bredius RG; ten Cate R
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23966458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial infections in a pediatric cohort of primary and acquired complement deficiencies.
    Al-Shaikhly T; Hayward K; Basiaga ML; Allenspach EJ
    Pediatr Rheumatol Online J; 2020 Sep; 18(1):74. PubMed ID: 32972440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual presentation of systemic lupus erythematosus.
    Mahesh E; Madhyastha PR; Varma V; Gurudev KC; Gireesh MS; Bande SR
    Saudi J Kidney Dis Transpl; 2017; 28(3):653-656. PubMed ID: 28540909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection.
    Tomita H; Yamada M; Sekigawa I; Yoshiike T; Iida N; Hashimoto H
    Clin Exp Rheumatol; 2003; 21(4):497-9. PubMed ID: 12942705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric-onset systemic lupus erythematosus.
    Malattia C; Martini A
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):351-62. PubMed ID: 24238692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain abscess caused by Micrococcus luteus in a patient with systemic lupus erythematosus: case-based review.
    Erbasan F
    Rheumatol Int; 2018 Dec; 38(12):2323-2328. PubMed ID: 30374688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the complement system in systemic lupus erythematosus.
    Sharma M; Vignesh P; Tiewsoh K; Rawat A
    Expert Rev Clin Immunol; 2020 Apr; 16(4):397-408. PubMed ID: 32228236
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic lupus erythematosus and lupus nephritis.
    Koutsokeras T; Healy T
    Nat Rev Drug Discov; 2014 Mar; 13(3):173-4. PubMed ID: 24525782
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors and bacterial profiles of urinary tract infections in patients with systemic lupus erythematosus.
    Tsai YC; Hou CL; Yao TC; Chen LC; Jaing TH; Huang JL
    Asian Pac J Allergy Immunol; 2007; 25(2-3):155-61. PubMed ID: 18035803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis
    Mitander A; Fei Y; Trysberg E; Mohammad M; Hu Z; Sakiniene E; Pullerits R; Jin T
    J Rheumatol; 2018 Nov; 45(11):1557-1564. PubMed ID: 30173146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
    das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
    Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of lupus nephritis.
    Jaryal A; Vikrant S
    Indian J Med Res; 2017 Feb; 145(2):167-178. PubMed ID: 28639592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year in review 2017: systemic lupus erythematosus.
    La Paglia GMC; Leone MC; Lepri G; Vagelli R; Valentini E; Alunno A; Tani C
    Clin Exp Rheumatol; 2017; 35(4):551-561. PubMed ID: 28721860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
    Iwata S; Saito K; Hirata S; Ohkubo N; Nakayamada S; Nakano K; Hanami K; Kubo S; Miyagawa I; Yoshikawa M; Miyazaki Y; Yoshinari H; Tanaka Y
    Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.
    Nossent JC; Bronsveld W; Swaak AJ
    Ann Rheum Dis; 1989 Oct; 48(10):810-6. PubMed ID: 2818017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus colitis following immunosuppressive therapy for lupus peritonitis and lupus nephritis.
    Ohashi N; Isozaki T; Shirakawa K; Ikegaya N; Yamamoto T; Hishida A
    Intern Med; 2003 Apr; 42(4):362-6. PubMed ID: 12729328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up.
    Chen MJ; Tseng HM; Huang YL; Hsu WN; Yeh KW; Wu TL; See LC; Huang JL
    Rheumatology (Oxford); 2008 Sep; 47(9):1352-7. PubMed ID: 18565988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman.
    Hong H; Yang R; Li X; Wang M; Ma Z
    BMC Nephrol; 2018 Apr; 19(1):90. PubMed ID: 29669532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis.
    Narain S; Berman N; Furie R
    Curr Opin Rheumatol; 2020 Nov; 32(6):609-616. PubMed ID: 33002950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.